Press release
Sickle Cell Disease Treatment Poised to Expand at a Healthy CAGR of 6.0% During the Forecast -2025
View Report Preview:
https://www.persistencemarketresearch.com/market-research/sickle-cell-disease-treatment-market.asp
Global Sickle Cell Disease Treatment Market: Drivers
Increasing discretionary research funding for Sickle cell anaemia in developed countries
Governments focus on creating awareness on sickle cell anemia cure
Aging population in developed economies and rising affluence in emerging markets to boost healthcare spending
Demand for drug therapy in combination with surgeries and blood transfusion
Changes in lifestyle to increase the probability of genomic mutations
Increasing penetration of FDA approved drugs in the market
Various key players in the sickle cell disease treatment market are signing partnerships and licensing deals to share the research and development platform
Reduction of overall diagnosis cost for sickle cell diseases
Global Sickle Cell Disease Treatment Market: Forecast by Drug Type
On the basis of drug type, the global sickle cell disease treatment market is segmented into hydroxyurea, antibiotics, pain-relieving medications, and Others. The hydroxyurea segment is likely to be accounted for 38.7 % market revenue share in 2017, which is expected to increase to 35.7% by 2025 end. This drug type is expected to account for a high revenue contribution in the global sickle cell disease treatment market as compared to other drug types over the forecast period. Hydroxyurea product is expected to be the second attractive drug type segment in sickle cell disease treatment market, with market attractiveness index of 1.2.
Global Sickle Cell Disease Treatment Market: Forecast by Disease Type
On the basis of disease type, the global sickle cell disease treatment market is segmented into sickle cell anemia, sickle hemoglobin C disease, and sickle beta thalassemia. Sickle cell anemia is expected to be the most lucrative among all disease type segment of sickle cell disease treatment market, with attractiveness index of 1.8. Sickle Beta Thalassemia is expected to be the second attractive drug type segment in sickle cell disease treatment market, with market attractiveness index of 0.7.
Global Sickle Cell Disease Treatment Market: Forecast by Distribution Channel
This segment include hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is expected to witness a significant rise in revenue share over the forecast period, owing to the increasing direct procurement of drugs by governments to ensure availability in hospital pharmacies. Hospital pharmacies is expected to be the most lucrative among all distribution channels of sickle cell disease treatment market, with attractiveness index of 2.5. Retail pharmacies is expected to be the second largest distribution channels of sickle cell disease treatment market, with market attractiveness index of 0.4
Global Sickle Cell Disease Treatment Market: Forecast by Region
Five regions such as North America, Latin America, Europe, APAC and MEA are covered in this report. MEA regions are pegged to represent the most lucrative markets, owing to the high prevalent cases of sickle cell diseases. The MEA sickle cell disease treatment market is expected to expand at a CAGR of 6.1 % in terms of value over the forecast period. Growing awareness and adoption of treatment for sickle cell disease in India and in the APAC region is expected to create a sizeable opportunity for the players in this market.
Request to view Sample Report:
https://www.persistencemarketresearch.com/samples/16099
Global Sickle Cell Disease Treatment Market: Key Players
These are the key players in the global sickle cell disease treatment market- AstraZeneca Plc., Eli Lilly and Company, Eli Lilly and Company, Novartis AG, Pfizer Inc., Baxter International Inc., Emmaus Life Sciences, Inc., Bluebird bio, Inc., Global Blood Therapeutics Inc., Sangamo Therapeutics, Inc., Acceleron Pharma, Inc., Arena Pharmaceuticals, Inc., and Alnylam Pharmaceuticals, Inc.
About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Contact Us
Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
T: +1-646-568-7751
Tollfree: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Web:www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sickle Cell Disease Treatment Poised to Expand at a Healthy CAGR of 6.0% During the Forecast -2025 here
News-ID: 839011 • Views: …
More Releases from Persistence Market Research
Global Memory Market Set for Strong Growth Driven by AI and Data Centers
The global memory market is entering one of its most transformative growth cycles in decades. As digital ecosystems scale rapidly across artificial intelligence (AI), cloud computing, data centers, automotive electronics, and edge devices, memory technologies are becoming the backbone of modern computing infrastructure. From high-performance servers to connected vehicles and IoT endpoints, memory capacity, speed, and efficiency now directly influence system performance and competitiveness.
The global memory market size is likely…
Why Network Traffic Analyzers Are Becoming Critical for Modern Enterprises
The global digital ecosystem is undergoing an unprecedented transformation as enterprises, governments, and service providers become increasingly dependent on high-performance, always-on networks. In this environment, understanding how data flows across networks is no longer optional-it is mission-critical. Network traffic analyzers have emerged as essential tools that enable organizations to monitor, inspect, and optimize network performance while defending against escalating cyber risks.
The global network traffic analyzer market is likely to be…
Storage Adapter Market Accelerates with High-Speed Data and Cloud Demand
The storage adapter market plays a critical role in modern IT infrastructure by enabling seamless communication between servers and storage systems. Storage adapters-such as host bus adapters (HBAs), RAID controllers, and converged network adapters-are essential for managing high-speed data transfer, low latency, and reliable connectivity across enterprise data centers, cloud platforms, and hyperscale environments. As data volumes surge and workloads become more complex, storage adapters have evolved from basic connectivity…
Pregelatinized Starch Market US$2.4 Bn by 2033 Driven by Food Processing Demand
The global pregelatinized starch market is poised for consistent growth over the coming years, supported by rising demand across food processing, pharmaceuticals, paper, textiles, and other industrial applications. In 2026, the global pregelatinized starch market size is expected to be valued at approximately US$ 1.7 billion. With increasing adoption across both developed and emerging economies, the market is projected to reach around US$ 2.4 billion by 2033. This growth trajectory…
More Releases for Sickle
Sickle Cell Disease Treatment Market - Improving Quality of Life: Pioneering Sic …
Newark, New Castle, USA: The "Sickle Cell Disease Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Sickle Cell Disease Treatment Market: https://www.growthplusreports.com/report/sickle-cell-disease-treatment-market/7808
This latest report researches the…
Sickle Cell Disease Treatment Market - Breaking the Chains of Sickle Cell: Pione …
Newark, New Castle, USA - new report, titled Sickle Cell Disease Treatment Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Sickle Cell Disease Treatment market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Sickle Cell Disease Treatment market. The report offers…
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The sickle cell disease treatment market is a segment of the broader pharmaceutical industry that is focused on developing treatments for sickle cell disease, a genetic disorder that affects the red blood cells. In 2022, the sickle cell disease treatment market is expected to continue to grow, driven by the increasing prevalence of the disease and the development of new treatments. The market is expected to be worth billions of…
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The sickle cell disease treatment market refers to the segment of the healthcare industry that produces and markets treatments for sickle cell disease (SCD), a genetic disorder that affects the production of hemoglobin in red blood cells. SCD can cause various complications, including pain, infections, and organ damage, and there is currently no cure for the disease. However, various treatments are available that can help manage the symptoms and improve…
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The sickle cell disease treatment market refers to the segment of the pharmaceuticals industry that deals with the production and sales of treatments for sickle cell disease. Sickle cell disease is a genetic blood disorder that causes red blood cells to become misshapen and form a sickle shape. This can lead to a range of complications, including anemia, chronic pain, and increased risk of infections.
The market for sickle cell disease…
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The Sickle Cell Disease Treatment Market is an emerging segment in the healthcare industry. This debilitating disorder affects millions of people around the world, with no known cure available. However, recent advances in research have improved the treatment options for those suffering from sickle cell disease. The Sickle Cell Disease Treatment Market is expected to experience significant growth over the coming years as treatments become more effective and accessible. Several…
